Tag: ludwig-burger

  • Johnson & Johnson approaches Actelion about takeover deal

    By Paul Arnold and Ludwig Burger ZURICH/FRANKFURT (Reuters) – U.S. healthcare company Johnson & Johnson said on Friday it was in preliminary talks with Actelion about a potential takeover of Europe's largest biotech firm, currently valued at about $20 billion. Lung disease specialist Actelion confirmed it had been approached and said there was no certainty…

  • With LGBT-friendly policies, more women claim sexual minority status

    By Andrew M. Seaman (Reuters Health) – U.S. women may be more likely to report that they belong to a sexual minority if they live in states that recognize same-sex relationships, according to a new study. The finding is drawn from data on 69,790 participants in the Nurses’ Health Study II, which started in 1989…

  • Roche beats forecasts on new drugs and one-off gain

    By Ludwig Burger BASEL, Switzerland (Reuters) – Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs…

  • Roche beats forecasts on new drugs and one-off gain

    By Ludwig Burger BASEL, Switzerland (Reuters) – Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs…

  • Researchers developing effective chlamydia vaccine

    Researchers at McMaster University, Canada, have presented the first promising steps towards a vaccine against chlamydia, a “silent” sexually transmitted infection (STI) that affects 113 million people worldwide each year and which can lead to infertility. The research, published in the journal Vaccine, could help protect people all over the world from chlamydia. If left…